South Asian Melioidosis Congress 2017
South Asian Melioidosis Congress 2017
批准号:
9398260
负责人:
HERBERT P. SCHWEIZER
金额:
$0.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-10 至 2018-07-31
关键词:
AddressAffectAreaAsiaAwarenessBacteriaBurkholderia pseudomalleiCase Fatality RatesClinicalClinical MicrobiologyCollaborationsCommunicable DiseasesCommunitiesCongressesCountryDengueDiabetes MellitusDiagnosisDiagnosticDiseaseEmerging Communicable DiseasesEuropeanFundingGram-Negative BacteriaHabitatsHealth PersonnelHumanIndiaIndividualKnowledgeLaboratoriesLeptospirosisMalariaMelioidosisPopulationPopulations at RiskPreventionPublic HealthResearchResearch PersonnelRiskRisk FactorsScheduleSecureSouth AsianSri LankaStudentsTherapeuticTravelTuberculosisUrsidae Familyburden of illnessclinical practicehuman mortalityinterestmeetingsmortalitypreventsymposium
中文摘要
提案摘要
类鼻疽是一种由革兰氏阴性杆菌伯克霍尔德氏菌引起的新发传染病
假鼻疽大多数情况下,这种细菌的栖息地仅限于热带地区,
地球仪。据估计,全球面临风险的人口超过30亿。虽然案件数量
显著低于肺结核、疟疾、钩端螺旋体病和
例如,在登革热中,人类类鼻疽病的全球致死率显著高于例如登革热,
钩端螺旋体病因此,就死亡率而言,类鼻疽可能是主要的“杀手”之一。
热带疾病。全世界对类鼻疽的兴趣越来越大,
认识到认识、诊断、治疗和预防是一个重大的公共卫生问题
重要性也许没有什么地方比南亚更受关注了。据估计,这一地区
承担着全球类鼻疽负担的44%,但对该疾病及其细菌原因的认识仍然存在,
很低因此,迫切需要不断召集专题专家,
临床医生,学者,卫生保健工作者和学生传播知识,教育,
将我们对类鼻疽病及其细菌病因B的不断发展的知识投入临床实践。假鼻疽
这项申请的具体目的是确保旅行、住宿和登记的资金,
使至少10-12个人-主要是实习生水平的临床研究人员,博士后研究人员,
和学生-参加第二届南亚类鼻疽会议(SAMC 2017),将在
2017年8月29日至30日,斯里兰卡科隆博。SAMC 2017的主要目标是汇集
75-100名主题专家、临床医生、院士、学生和卫生保健工作者:1)
交流和讨论来自学术实验室和临床环境的新发现; 2)讨论
将适当的诊断和治疗方法投入临床实践,以控制和预防
类鼻疽病;以及3)旨在通过发展和/或维持
强有力的合作和在南亚及其他地区随时传播信息的方式。的
从2015年在印度马尼帕尔举行的第一届南亚类鼻疽病会议上吸取的经验教训,
这清楚地表明,南亚目前的需求是特殊的,任何一个国家都无法满足这些需求。
其他定期安排的类鼻疽会议。
英文摘要
Proposal Summary
Melioidosis is an emerging infectious disease caused by the Gram-negative bacterium Burkholderia
pseudomallei. Mostly confined to the tropics the bacterium's established habitat reaches around the
globe. The global at risk population is estimated at >3 billion people. Although case numbers are
significantly lower than those of well-known diseases such as tuberculosis, malaria, leptospirosis and
dengue, the global fatality of human melioidosis is substantially higher than that of e.g. dengue and
leptospirosis. Hence, in terms of mortality melioidosis could potentially be one of the main “killer”
diseases of the tropics. There is an increasing interest in melioidosis worldwide, and a growing
realization that awareness, diagnosis, treatment and prevention are a matter of great public health
importance. Perhaps nowhere is the interest higher than in South Asia. This is a region estimated to
bear 44% of the global melioidosis burden, yet awareness of the disease and its bacterial cause remains
very low. There is therefore an urgent and continuing need to bring together subject matter experts,
clinicians, academicians, health care workers, and students to disseminate knowledge, to educate, and
to put into clinical practice our evolving knowledge of melioidosis and its bacterial cause B. pseudomallei.
The specific aim of this application is to secure funds for travel, accommodation and registration to
enable at least 10-12 individuals – mostly trainee level clinical researchers, postdoctoral researchers,
and students - to attend the 2nd South Asian Melioidosis Conference (SAMC2017) that will be held in
Colombo, Sri Lanka, from August 29-30, 2017. The main objectives of SAMC2017 are to bring together
75-100 subject matter experts, clinicians, academicians, students, and health care workers to: 1)
communicate and discuss new findings from academic laboratories and clinical settings; 2) discuss
strategies to put into clinical practice proper diagnostics and therapeutics to control and prevent
melioidosis; and 3) aim to sustain such efforts beyond the conference by developing and/or maintaining
strong collaborations and ways to readily disseminate information in South Asia and beyond. The
lessons learned from the 1st South Asian Melioidosis Conference that was held in 2015 in Manipal, India,
clearly showed that the current needs in South Asia are special and that they cannot be met by any of
the other regularly scheduled melioidosis meetings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Emerging antibiotic resistance in Gram-negative pathogens
-
批准号:10548230
-
项目类别:
-
资助金额:$66.71万
-
财政年份:2019
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Emerging antibiotic resistance in Gram-negative pathogens
-
批准号:10328513
-
项目类别:
-
资助金额:$66.71万
-
财政年份:2019
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Emerging antibiotic resistance in Gram-negative pathogens
-
批准号:9752147
-
项目类别:
-
资助金额:$67.89万
-
财政年份:2019
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Emerging antibiotic resistance in Gram-negative pathogens
-
批准号:10083704
-
项目类别:
-
资助金额:$66.71万
-
财政年份:2019
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.
-
批准号:8605839
-
项目类别:
-
资助金额:$3.59万
-
财政年份:2013
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.
-
批准号:9027352
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2013
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.
-
批准号:8512182
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2013
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Burkholderia pseudomallei antimicrobial resistance mechanisms
-
批准号:8261423
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2011
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Developmental Research Projects
-
批准号:8261419
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2011
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
World Melioidosis Congress 2010
-
批准号:8063010
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2010
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Burkholderia pseudomallei antimicrobial resistance mechanisms
-
批准号:7675611
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2009
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Developmental Research Projects
-
批准号:7675542
-
项目类别:
-
资助金额:$53.49万
-
财政年份:2009
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Evaluation of Novel Meliodosis Therapeutics
-
批准号:7688234
-
项目类别:
-
资助金额:$15.68万
-
财政年份:2008
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
RMRCE Devlopmental Research Projects
-
批准号:7690448
-
项目类别:
-
资助金额:$57.44万
-
财政年份:2008
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Burkholderia ssp. Novel Therapeutic Approaches
-
批准号:7641023
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2008
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Non-antiobiotic resistance markers for bacteria
-
批准号:6957034
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2005
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Non-antiobiotic resistance markers for bacteria
-
批准号:7140243
-
项目类别:
-
资助金额:$17.55万
-
财政年份:2005
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Burkholderia ssp. Novel Therapeutic Approaches
-
批准号:7126633
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2005
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Genetic Tools for Pathogenic Bacteria
-
批准号:6819459
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2004
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
Genetic Tools for Pathogenic Bacteria
-
批准号:6917168
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2004
-
负责人:HERBERT P. SCHWEIZER
-
依托单位:
海外基金